Clin2
NCT07368062Worth exploringRecruiting

Mental health after a heart rhythm drug in the ICU

Mental Health

Treatments studied

Part of Heart & circulation clinical trials.

This study looks at the long-term mental health of people who received a drug called dexmedetomidine during an electrical storm (a dangerous heart rhythm) in the ICU.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
70 people
Ages
Any age
Study type
Observational

Who can take part

  • You have been diagnosed with a serious heart rhythm problem called electrical storm in the last 6 months.
  • You were in an intensive care unit (ICU) because of this problem.
  • You took part in a previous study called SEDATE.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06281977Recruiting· Phase 3
Dexmedetomidine for electrical storm in the ICU

This trial tests if a medication called dexmedetomidine (a sedative that can also stabilize heart rhythm) helps calm electrical storms—dangerous, repeated episodes of fast heartbeats. It is for people in the intensive care unit who are experiencing this emergency.

Rochester, Minnesota
NCT04289142Recruiting· Phase 4
Testing memory effects of dexmedetomidine during heart surgery

This study looks at how a sleep medicine called dexmedetomidine affects thinking and memory after heart surgery. It compares cognitive outcomes over time to see if this sedation choice changes long-term brain function.

Vancouver, British Columbia
NCT06620393Not yet recruiting· Phase 2/Phase 3
Study of dexmedetomidine for agitation in brain injury ICU patients

This trial tests a sedative drug (dexmedetomidine) to see if it helps calm agitation in patients with moderate or severe traumatic brain injury who are on a breathing machine in the ICU. The goal is to improve comfort and recovery.

NCT07377981Not yet recruiting· Phase 4
New drug combo for agitation in ICU delirium patients

This trial tests if combining two medicines, esketamine and dexmedetomidine, is better than dexmedetomidine alone for calming severe confusion and agitation in ICU patients who need breathing support through a mask or nasal tubes. It aims to find a safer, more effective way to help patients rest and recover.

Nanjing, Jiangsu
NCT06003127Recruiting
Recovery from dexmedetomidine-induced unconsciousness

This study explores how people recover after being given a common sedative called dexmedetomidine. It may help doctors better understand and manage recovery from sedation.

Boston, Massachusetts
NCT06468436Not yet recruiting
Medicine combo for sedation in ICU patients

This study tests a combination of two medicines, dexmedetomidine and esketamine, to help keep ICU patients calm and comfortable while on a breathing machine. The goal is to see if this combination works well for sedation and pain relief.

Beijing, Beijing Municipality

Hear when a new Mental Health trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.